Skip to content
Lower risk Medical device recall · FDA · Published February 21, 2023

Limacorporate SMR TT Hybrid Glenoid Recall: No Tantalum Markers Risk

Limacorporate recalls SMR TT Hybrid glenoid implants without tantalum markers. Without markers, doctors may misjudge implant position during X-rays, risking improper joint alignment.

🇺🇸 FDA recall #Z-1317-2023Medical deviceLimacorporate ›
Take action

Contact the company

Recalling firmLimacorporate S.p.AVia Nazionale 52, Di San Daniele · San Daniele Del Friuli, Italy
✎ GovInfoNow plain-language explainer

Limacorporate is recalling a specific type of shoulder implant (SMR TT Hybrid glenoid Std - Peg S) because it lacks tantalum markers. This means doctors might misjudge the implant's position during X-rays, potentially leading to improper joint alignment if not corrected. Read more at govinfonow.com/recall/58867-limacorporate-smr-tt-hybrid-glenoid-recall-no-tantalum-markers-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/58867-limacorporate-smr-tt-hybrid-glenoid-recall-no-tantalum-markers-risk · Updated August 19, 2026 · FDA enforcement record: FDA #Z-1317-2023

Cite this page

“Limacorporate SMR TT Hybrid Glenoid Recall: No Tantalum Markers Risk.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/58867-limacorporate-smr-tt-hybrid-glenoid-recall-no-tantalum-markers-risk. Based on FDA recall #Z-1317-2023 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1317-2023%22&limit=1).

The FDA announced on Feb. 21, 2023, that Limacorporate S.p.A. is recalling the SMR TT Hybrid glenoid Std - Peg S shoulder prosthesis because it was manufactured without tantalum markers. This defect prevents correct radiographic assessment of the implant position.

How to tell if you have it

  • Brand: Limacorporate
  • Product: SMR TT Hybrid glenoid Std - Peg S
  • REF: 1379.59.210
  • UDI-DI/Lot/Expiration: 08033390121798/2206565/2027-04-30
  • Distribution: Missouri

The hazard

The shoulder glenoid fossa prosthesis was manufactured without tantalum markers. In the absence of these markers, a correct radiographic assessment of the hybrid glenoid position cannot be performed via standard imaging.

Context

GovInfoNow's records show Limacorporate S.p.A has issued 8 other recalls since Sept. 8, 2017. Recent brand recalls include a May 19, 2025 recall for the PRIMA 2MM Eccentric Adaptor due to missing screw risk and an Oct. 2, 2024 recall for TEMA Elbow Prostheses involving potential surgical risk. Other recent recalls of similar products include the July 13, 2026 Straumann GM Helix Dental Implant Recall for packaging mismatch risk and the March 17, 2026 Straumann Custom Abutment Ti Recall for material mix-up risk.

How to tell if you have this one

Check for the model name 'SMR TT Hybrid glenoid Std - Peg S' and reference number 1379.59.210 on the implant. The implant was sold between 2027 and 2027 (expiration date: 2027-04-30).

  • Brand
    Limacorporate
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Implant Details

    Look for the model name 'SMR TT Hybrid glenoid Std - Peg S' and reference number 1379.59.210 on the implant.

Where it went and when

Where it was distributed

Distributed in Missouri.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: not listedILWisconsin: not listedWIMichigan: not listedMINew York: not listedNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: not listedOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: not listedCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: yesMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: not listedTXFlorida: not listedFL

FDA distribution: “US: MO” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Missouri.

Recall timeline

FDA published this recall 43 days after the firm started it.

1. Firm started the recall: Feb 21, 202312. FDA classified it Class II: Mar 30, 202323. Published in FDA’s Enforcement Report: Apr 5, 202332023
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-1317-2023 (February 21, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1317-2023 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA